Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-397-5 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Ames test: The test substance is not mutagenic in the Ames test and Escherichia reverse mutation assay under the experimental conditions chosen.
HPRT test: The test substance is not mutagenic in the HPRT test under the experimental conditions chosen.
Chromosome aberration test: The test substance induced no structural and no numerical chromosome aberrations and was shown to be not a chromosome-damaging (clastogenic) under the experimental conditions chosen.
Link to relevant study records
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.10 (Mutagenicity - In Vitro Mammalian Chromosome Aberration Test)
- Version / remarks:
- Official Journal of European Communities No L383A/148, 29 December 1992
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Department of Toxicology of BASF SE, Ludwigshafen/Rhein, Germany
- Type of assay:
- other: chromosome aberration test
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: 34-0725 - Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254-induced rat liver S9 mix
- Test concentrations with justification for top dose:
- 1st experiment (with/without S9 mix, 18 h harvest):
962.5, 1925, 3850 µg/mL (based on the aqueous test substance)
[385.0, 770.0, 1540.0 µg/mL (based on the active ingredient)]
2nd experiment (without S9 mix, 18 harvest):
1925, 2887.5, 3850 µg/mL (based on the aqueous test substance)
[770.0, 1155.0, 1540.0 µg/mL (based on the active ingredient)]
3rd experiment (with/without S9 mix):
18 h harvest: 1925, 2887, 3850 µg/mL (based on the aqueous test substance)
[770.0, 1155.0, 1540.0 µg/mL (based on the active ingredient)]
28 h harvest: 3850 µg/mL (based on the aqueous test substance)
[1540.0 µg/mL (based on the active ingredient)] - Vehicle / solvent:
- Vehicle(s)/solvent(s) used: Minimal essential medium (MEM including glutamine)
Justification for choice of solvent/vehicle: Due to the good solubility of the test substance in water, the aqueous culture medium (MEM) was selected as the vehicle. - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- ethylmethanesulphonate
- Remarks:
- without metabolic activation, 0.350 mg/mL
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- with metabolic activation, 0.0005 mg/mL
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: In medium
DURATION
- Preincubation period: 4 h with S9 mix
- Exposure duration: 18 and 28 hours
- Fixation time (start of exposure up to fixation or harvest of cells): 24 and 30 hours
SPINDLE INHIBITOR: Two - three hours before each preparation time (18 and 28 hours after the beginning of treatment) 0.2 µg colcemide/mL culture medium was added to each well to arrest mitosis in the metaphases. The medium was removed and replaced with 5 mL of a hypotonic solution (0.4 % KCI in dist . water) pre-warmed to 37°C for about 20 min. Thereafter the cells were fixed with 5 mL of ice-cold fixative (methanol : glacial acetic acid = 3 : 1).
STAIN: 10 min in a solution of Giemsa and Titrisol (15 mL Giemsa, 185 mL Titrisol, pH 7.2)
NUMBER OF REPLICATIONS: Two independent experiments were performed.
NUMBER OF CELLS EVALUATED: first 100 consecutive well spread metaphases of each culture (20 - 22 chromosomes).
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index (1000 ceels/culture)
OTHER EXAMINATIONS:
- Determination of polyploidy: Yes - Evaluation criteria:
- The test chemical is to be considered positive in this assay if the following criteria are met :
- a dose-related and reproducible significant increase in the number of structural chromosomal aberrations .
- the proportion of aberrations exceeded both the concurrent negative control range and the negative historical control range .
A test substance is generally considered nonclastogenic in this test system if :
- there was no significant increase in the number of chromosomally damaged cells at any dose above concurrent control frequencies .
- the aberration frequencies were within the historical control range . - Statistics:
- The proportion of metaphases with aberrations was calculated for each group. A comparison of each dose group with the vehicle control group was carried outusing Fisher's exact test for the hypothesis of equal proportions. This test was Bonferroni-Holm corrected versus the dose groups separately for each time and was performed one-sided.
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- 1st experiment:
With 7.5% there was a slight increase in the number of aberrant cells at the highest dose of 3850 µg/mL in the experimental part without metabolic activation after a harvest time of 18 hours . However, this figure which slightly exceeded the upper value of the historical control range, i .e .5.5% was influenced by only one out of the two cultures.
With S9 mix an increase in the number of aberrant metaphases was not observed.
2nd experiment:
For confirmation/substantiation of the findings of the 1st experiment the 2nd experiment was limited to the experimental part without S9 mix only but selecting closer doses to demonstrate a possible dose-response relationship. However, the results of the 1st experiment could not be confirmed, i. e. the number of chromosomally damaged cells was within the range of the concurrent negative control and within the range of the historical control data.
3rd experiment:
In the 3rd experiment including an additionally harvest time of 28 hours a clastogenic activity could not be observed after any of the experimental conditions. - Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1989-03-07
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 472 (Genetic Toxicology: Escherichia coli, Reverse Mutation Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Department of Toxicology of BASF SE, Ludwigshafen/Rhein, Germany
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: P. 49206/88
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: 4 °C - 6 °C - Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254-induced rat liver S9 mix
- Test concentrations with justification for top dose:
- 1st Experiment: S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2 uvr A
0, 100, 500, 2500, 5000, 7500 µg/plate (based on the aqueous test substance)
[0, 40, 200, 1000, 2000, 3000 µg/plate (based on the active ingredient)]
2nd Experiment: S. typhimurium TA 1535, TA 1537, TA 98, TA 100
0, 100, 500, 2500, 5000, 7500 µg/plate (based on the aqueous test substance)
[0, 40, 200, 1000, 2000, 3000 µg/plate (based on the active ingredient)]
3rd Experiment: E. coli WP2 uvr A
0, 100, 500, 2500, 5000, 7500 µg/plate (based on the aqueous test substance)
[0, 40, 200, 1000, 2000, 3000 µg/plate (based on the active ingredient)] - Vehicle / solvent:
- Vehicle used: Water
Justification for choice of vehicle: Due to the good solubility of the test substance in water, water was selected as the vehicle. - Untreated negative controls:
- yes
- Remarks:
- sterility and vehicle control
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-Aminoanthracen (2-AA)
- Remarks:
- With S9 mix: TA 1535, TA 100, TA 1537, TA 98 (10 µg), E.coli (60 µg)
- Untreated negative controls:
- yes
- Remarks:
- sterility and vehicle control
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: N-methyl-N' -nitro-N-nitrosoguanidine (MNNG)
- Remarks:
- Without S9 mix, TA 1535, TA 100 (5 µg)
- Untreated negative controls:
- yes
- Remarks:
- sterility and vehicle control
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 4-nitro-o-phenyleridiamine (NOPD)
- Remarks:
- Without S9 mix, TA 98, (10 µg)
- Untreated negative controls:
- yes
- Remarks:
- sterility and vehicle control
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- Remarks:
- Without S9 mix, 100µg, TA 1537
- Untreated negative controls:
- yes
- Remarks:
- sterility and vehicle control
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- N-ethyl-N-nitro-N-nitrosoguanidine
- Remarks:
- Without S9 mix, 10 µg, E.coli
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: In agar (standard plate test) and preincubation test
DURATION
- Preincubation period: about 20 min at 37 °C
- Expression period: 48 hours at 37°C
NUMBER OF REPLICATIONS: 3 - Evaluation criteria:
- The test chemical is considered positive in this assay if the following criteria are met:
- doubling of the spontaneous mutation rate (control)
- dose-response relationship
- reproducibility of the results . - Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: No
COMPARISON WITH HISTORICAL CONTROL DATA: No - Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: EEC Directive 87/302, p61
- Version / remarks:
- May 1988
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Department of Toxicology of BASF SE, Ludwigshafen/Rhein, Germany
- Type of assay:
- in vitro mammalian cell transformation assay
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: 34-0725 - Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Remarks:
- Substrain: K1
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254-induced rat liver S9 mix
- Test concentrations with justification for top dose:
- 1st experiment:
240.625, 481.25, 962.5, 1925.0, 3850.0 µg/mL (based on the aqueous test substance)
[96.25, 192.5, 385.0, 770.0, 1540.0 µg/mL (based on the active ingredient)]
2nd experiment:
250.0, 500.0, 1000.0, 2000.0, 3000.0, 4000.0 µg/mL (based on the aqueous test substance)
[100.0, 200.0, 400.0, 800.0, 1200.0, 1600.0 µg/mL(based on the active ingredient)] - Vehicle / solvent:
- Vehicle(s)/solvent(s) used: Ham' F12 medium
Justification for choice of solvent/vehicle: Due to the good solubility of the test substance in water, the aqueous culture medium (Ham's F12) was selected as the vehicle. - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- ethylmethanesulphonate
- Remarks:
- without S9 mix, 0.3 mg/mL
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 3-methylcholanthrene
- Remarks:
- with S9 mix, 0.01 mg/mL
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium filled flasks
DURATION
- Exposure duration: 4 hours, thereafter serum-free medium was replaced by Ham's F12 with 10% FCS after being rinsed twice with Hanks' balanced salt solution (HBSS) . Subsequently, the flasks were incubated for another 17 - 24 h ; two flasks were pooled in each case and then subcultured (1st passage). After two further passages (duration of the expression period is about 1 week), cells were transferred into selection medium B (TG medium) at the 4th passage.
NUMBER OF REPLICATIONS: Two independent experiments, each with/without S9 mix
NUMBER OF CELLS EVALUATED: For the selection of the mutants, 6 x 300000 cells from each treatment group were seeded in six 75 cm² flasks with selection medium B (TG-medium) at the end of the expression period and the flasks then returned to the incubator for about 1 week . At the end of the selection period, colonies were fixed with methanol, stained with Giemsa and counted.
DETERMINATION OF CYTOTOXICITY
- Method: cloning efficiency (survival and viability) - Evaluation criteria:
- The criteria for a positive response are:
- Increases of the corrected mutation frequencies over the concurrent negative control values and over 15 mutants per 10E6 clonable and/or the evidence of a dose response relationship in the increase in mutation frequencies.
- Evidence of reproducibility of any increase in mutation frequencies.
- Statistically significant increase in mutant frequencies and the evidence of a dose-response relationship .
Isolated increases of mutation frequencies above 15 mutants per 10E6 clonable cells or isolated statistically significant increases without a doseresponse relationship may indicate a biological effect but are not regarded as sufficient evidence of mutagenicity. - Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- In the 1st experiment there was an increase in the mutant frequency without S9 mix at a dose of 962.5 μg/mL . However, this finding is not considered to be of any biological significance for the following reasons:
- Increased figures were observed only in one out of two parallel determinations.
- This increase is due to a calculation of the mutant frequency based on a relatively low cloning efficiency.
- There was no dose-response relationship.
- The findings could not be confirmed in an independently repeated experiment.
Referenceopen allclose all
Table 1: Experiment 1, harvest time 18 hours, treatment 18 h (-S9 mix) or 4 h (+S9 mix), mean of two cultures
|
|
|
Metaphases with aberrations |
|
|
||||
conc. [µg/mL] |
S9 mix |
Mitotic index % (mean) |
Incl. gap |
Excl.gap |
Exchanges |
Mul. Aber. |
Chr. Dis. |
Aneupl. |
Polypl. |
Vehicle control (MEM) |
- |
6.8 |
18 |
6 |
1 |
0 |
0 |
0 |
0 |
962.5# |
- |
5.6 |
20 |
7 |
2 |
0 |
0 |
0 |
0 |
1925.0 |
- |
6.1 |
13 |
8 |
3 |
0 |
0 |
0 |
0 |
3850.0 |
- |
6.9 |
16 |
13 |
10 |
0 |
0 |
0 |
0 |
Positive control (EMS) 350.0 |
- |
5.7 |
16 |
13 |
9 |
1 |
0 |
0 |
0 |
|
|
|
|
|
|
|
|
|
|
Vehicle control (MEM) |
+ |
11.5 |
12 |
3 |
3 |
0 |
0 |
0 |
0 |
962.5 |
+ |
12.8 |
17 |
6 |
3 |
0 |
0 |
0 |
0 |
1925.0 |
+ |
10.6 |
9 |
6 |
2 |
0 |
0 |
0 |
0 |
3850.0 |
+ |
12.8 |
15 |
5 |
5 |
0 |
0 |
0 |
0 |
Positive control (CPP) 0.5 |
+ |
7.0 |
21 |
18 |
9 |
0 |
0 |
0 |
0 |
# concentrations related to aqueous test substance, MEM = Minimal essential medium, EMS = ethyl methane sulfonate, CCP = Cyclophosphamide, Incl. = Including, Excl. = excluding, Mul. = multiple, Aber.= aberrations, Chr. = chromosome, Dis. = disintegration, aneupl. = aneuploidy, Polypl. = polyploidy |
Table 2: Experiment 2, harvest time 18 hours, treatment 18 h (-S9 mix), mean of two cultures
|
|
|
Metaphases with aberrations |
|
|
||||
conc. [µg/mL] |
S9 mix |
Mitotic index % (mean) |
Incl. gap |
Excl.gap |
Exchanges |
Mul. Aber. |
Chr. Dis. |
Aneupl. |
Polypl. |
Vehicle control (MEM) |
- |
5.2 |
14 |
7 |
1 |
0 |
0 |
0 |
1 |
1925# |
- |
4.9 |
17 |
4 |
1 |
0 |
0 |
1 |
1 |
2887.5 |
- |
7.2 |
11 |
2 |
0 |
0 |
0 |
0 |
0 |
3850.0 |
- |
6.0 |
22 |
6 |
1 |
0 |
0 |
1 |
0 |
Positive control (EMS) 350.0 |
- |
3.8 |
25 |
13 |
4 |
1 |
0 |
0 |
0 |
# concentrations related to aqueous test substance, MEM = Minimal essential medium, EMS = ethyl methane sulfonate, CCP = Cyclophosphamide, Incl. = Including, Excl. = excluding, Mul. = multiple, Aber.= aberrations, Chr. = chromosome, Dis. = disintegration, aneupl. = aneuploidy, Polypl. = polyploidy |
Table 3: Experiment 3, harvest time 18 hours, treatment 18 h (-S9 mix) or 4 h (+S9 mix), mean of two cultures
|
|
|
Metaphases with aberrations |
|
|
||||
conc. [µg/mL] |
S9 mix |
Mitotic index % (mean) |
Incl. gap |
Excl.gap |
Exchanges |
Mul. Aber. |
Chr. Dis. |
Aneupl. |
Polypl. |
Vehicle control (MEM) |
- |
6.5 |
15 |
6 |
1 |
0 |
0 |
1 |
0 |
1925# |
- |
4.6 |
15 |
8 |
4 |
0 |
0 |
0 |
0 |
2887.5 |
- |
4.2 |
15 |
9 |
2 |
0 |
0 |
0 |
0 |
3850.0 |
- |
5.7 |
13 |
7 |
2 |
1 |
0 |
0 |
0 |
Positive control (EMS) 350.0 |
- |
4.7 |
14 |
14 |
11 |
0 |
0 |
0 |
0 |
|
|
|
|
|
|
|
|
|
|
Vehicle control (MEM) |
+ |
8.3 |
11 |
4 |
0 |
0 |
0 |
0 |
0 |
1925# |
+ |
13.5 |
20 |
9 |
2 |
0 |
0 |
0 |
1 |
2887.5 |
+ |
7.5 |
11 |
2 |
0 |
0 |
0 |
0 |
0 |
3850.0 |
+ |
7.7 |
8 |
6 |
0 |
0 |
0 |
0 |
0 |
Positive control (CPP) 0.5 |
+ |
5.6 |
18 |
16 |
7 |
1 |
0 |
0 |
0 |
# concentrations related to aqueous test substance, MEM = Minimal essential medium, EMS = ethyl methane sulfonate, CCP = Cyclophosphamide, Incl. = Including, Excl. = excluding, Mul. = multiple, Aber.= aberrations, Chr. = chromosome, Dis. = disintegration, aneupl. = aneuploidy, Polypl. = polyploidy |
Table 4: Experiment 3, harvest time 28 hours, treatment 18 h (-S9 mix) or 4 h (+S9 mix), mean of two cultures
|
|
|
Metaphases with aberrations |
|
|
||||
conc. [µg/mL] |
S9 mix |
Mitotic index % (mean) |
Incl. gap |
Excl.gap |
Exchanges |
Mul. Aber. |
Chr. Dis. |
Aneupl. |
Polypl. |
Vehicle control (MEM) |
- |
9.8 |
6 |
3 |
2 |
0 |
0 |
0 |
0 |
3850.0# |
- |
9.1 |
14 |
8 |
5 |
0 |
0 |
0 |
0 |
|
|
|
|
|
|
|
|
|
|
Vehicle control (MEM) |
+ |
8.9 |
14 |
6 |
1 |
0 |
0 |
0 |
0 |
3850.0 |
+ |
14.5 |
12 |
2 |
1 |
0 |
0 |
0 |
0 |
# concentrations related to aqueous test substance, MEM = Minimal essential medium, EMS = ethyl methane sulfonate, CCP = Cyclophosphamide, Incl. = Including, Excl. = excluding, Mul. = multiple, Aber.= aberrations, Chr. = chromosome, Dis. = disintegration, aneupl. = aneuploidy, Polypl. = polyploidy |
Table 1: Standard plate test, number of revertants per plate (mean of three plates)
|
S. typhimurium |
E.coli |
||||||||
strain TA98 |
strain TA100 |
strain TA1535 |
strain TA1537 |
WP2 uvrA |
||||||
conc. [µg/mL] |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
0 (water) |
22 |
32 |
139 |
134 |
17 |
22 |
10 |
10 |
24 |
28 |
100# |
22 |
34 |
138 |
140 |
22 |
24 |
10 |
10 |
23 |
30 |
500 |
20 |
29 |
133 |
150 |
19 |
23 |
8 |
12 |
26 |
27 |
2500 |
21 |
35 |
120 |
133 |
18 |
20 |
10 |
10 |
19 |
34 |
5000 |
20 |
24 |
103 |
119 |
18 |
21 |
8 |
9 |
20 |
27 |
7500 |
20 |
28 |
115 |
114 |
19 |
17 |
10 |
12 |
24 |
34 |
4-nitro-o-phenyleridiamine 10 µg |
560 |
|
|
|
|
|
|
|
|
|
2-Aminoanthracene 10 µg (S. typhimurium) 60 µg (E. coli) |
|
1123 |
|
1710 |
|
292 |
|
154 |
|
110 |
N-methyl-N' -nitro-N-nitrosoguanidine 5 µg |
|
|
2103 |
|
2300 |
|
|
|
|
|
9-aminoacridine 100 µg |
|
|
|
|
|
|
761 |
|
|
|
N-ethyl-N-nitro-N-nitrosoguanidine 10 µg |
|
|
|
|
|
|
|
|
267 |
|
# concentrations related to the aqueous test substance |
Table 2: Preincubation test, number of revertants per plate (mean of three plates)
|
S. typhimurium |
E.coli |
||||||||
strain TA98 |
strain TA100 |
strain TA1535 |
strain TA1537 |
WP2 uvrA |
||||||
conc. [µg/mL] |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
0 (water) |
27 |
41 |
122 |
|
21 |
19 |
12 |
|
19 |
39 |
100 |
23 |
42 |
119 |
|
22 |
21 |
10 |
|
24 |
40 |
500 |
27 |
34 |
127 |
|
21 |
21 |
12 |
|
26 |
46 |
2500 |
26 |
40 |
129 |
|
22 |
20 |
12 |
|
20 |
38 |
5000 |
24 |
37 |
120 |
|
20 |
21 |
10 |
|
27 |
35 |
7500 |
23 |
31 |
121 |
|
19 |
23 |
11 |
|
19 |
34 |
4-nitro-o-phenyleridiamine 10 µg |
877 |
|
|
|
|
|
|
|
|
|
2-Aminoanthracene 10 µg (S. typhimurium) 60 µg (E. coli) |
|
558 |
|
1163 |
|
299 |
|
109 |
|
123 |
N-methyl-N' -nitro-N-nitrosoguanidine 5 µg |
|
|
1760 |
|
767 |
|
|
|
|
|
9-aminoacridine 100 µg |
|
|
|
|
|
|
563 |
|
|
|
N-ethyl-N-nitro-N-nitrosoguanidine 10 µg |
|
|
|
|
|
|
|
|
750 |
|
# concentrations related to the aqueous test substance |
Table 1: Experiment 1: Mutant Frequency (without metabolic activation)
Conc. [µg/mL] |
Culture |
No. of colonies a) |
Mutant frequency (per 10E6 cells) |
||||||
Not corrected |
Corrected b) |
||||||||
Vehicle control (Ham’s F12) |
A |
0 |
3 |
3 |
3 |
4 |
5 |
6.95 |
9.46 |
B |
0 |
0 |
1 |
2 |
2 |
2 |
|||
240.625# |
A |
0 |
0 |
0 |
0 |
0 |
0 |
1.67 |
3.03 |
B |
0 |
0 |
1 |
1 |
2 |
2 |
|||
481.25 |
A |
0 |
0 |
1 |
1 |
1 |
2 |
7.78 |
13.18 |
B |
2 |
2 |
4 |
4 |
5 |
6 |
|||
962.5 |
A |
0 |
0 |
0 |
0 |
0 |
1 |
14.17 |
26.03 |
B |
5 |
6 |
7 |
8 |
11 |
13 |
|||
1925.0 |
A |
0 |
0 |
0 |
0 |
0 |
0 |
0.00 |
0.00 |
B |
0 |
0 |
0 |
0 |
0 |
0 |
|||
3850.0 |
A |
0 |
1 |
1 |
1 |
3 |
5 |
9.17 |
14.08 |
B |
2 |
3 |
3 |
3 |
5 |
6 |
|||
Positive control (EMS) 300.0 |
A |
61 |
61 |
65 |
70 |
72 |
77 |
203.89 |
305.44 |
B |
49 |
53 |
53 |
54 |
59 |
60 |
|||
# concentrations related to the aqueous test substance a) Number of colonies 7 days after seeding about 300 .000 cells/flask into selection medium b) Correction applies to the absolute cloning efficiency at the end of the expression period |
Table 2: Experiment 1: Mutant Frequency (with metabolic activation)
Conc. [µg/mL] |
Culture |
No. of colonies a) |
Mutant frequency (per 10E6 cells) |
||||||
Not corrected |
Corrected b) |
||||||||
Vehicle control (Ham’s F12) |
A |
0 |
0 |
0 |
1 |
2 |
2 |
7.50 |
9.79 |
B |
2 |
2 |
3 |
4 |
5 |
6 |
|||
240.625# |
A |
0 |
1 |
1 |
2 |
2 |
3 |
4.72 |
7.20 |
B |
0 |
1 |
1 |
1 |
2 |
3 |
|||
481.25 |
A |
2 |
2 |
3 |
3 |
4 |
4 |
6.95 |
8.35 |
B |
0 |
1 |
1 |
1 |
2 |
2 |
|||
962.5 |
A |
1 |
1 |
2 |
2 |
3 |
4 |
3.89 |
5.96 |
B |
0 |
0 |
0 |
0 |
0 |
1 |
|||
1925.0 |
A |
0 |
2 |
4 |
4 |
5 |
10 |
9.73 |
11.59 |
B |
0 |
1 |
1 |
2 |
2 |
4 |
|||
3850.0 |
A |
0 |
0 |
1 |
1 |
1 |
2 |
1.95 |
2.57 |
B |
0 |
0 |
0 |
0 |
1 |
1 |
|||
Positive control (EMS) 300.0 |
A |
97 |
101 |
102 |
110 |
111 |
112 |
345.56 |
554.38 |
B |
96 |
97 |
99 |
99 |
101 |
119 |
|||
# concentrations related to the aqueous test substance a) Number of colonies 7 days after seeding about 300 .000 cells/flask into selection medium b) Correction applies to the absolute cloning efficiency at the end of the expression period |
Table 3: Experiment 2: Mutant Frequency (without metabolic activation)
Conc. [µg/mL] |
Culture |
No. of colonies a) |
Mutant frequency (per 10E6 cells) |
||||||
Not corrected |
Corrected b) |
||||||||
Vehicle control (Ham’s F12) |
A |
1 |
2 |
3 |
5 |
5 |
5 |
5.84 |
7.37 |
B |
0 |
0 |
0 |
0 |
0 |
0 |
|||
250.0# |
A |
0 |
0 |
0 |
1 |
1 |
2 |
3.33 |
3.76 |
B |
0 |
0 |
1 |
2 |
2 |
3 |
|||
500.0 |
A |
0 |
1 |
1 |
2 |
3 |
3 |
3.34 |
3.65 |
B |
0 |
0 |
0 |
0 |
1 |
1 |
|||
1000.0 |
A |
0 |
0 |
0 |
0 |
0 |
0 |
0.56 |
0.54 |
B |
0 |
0 |
0 |
0 |
1 |
1 |
|||
2000.0 |
A |
0 |
0 |
0 |
0 |
0 |
3 |
2.78 |
3.20 |
B |
0 |
0 |
|
1 |
2 |
3 |
|||
3000.0 |
A |
0 |
0 |
0 |
0 |
0 |
1 |
1.12 |
1.18 |
B |
0 |
0 |
0 |
0 |
1 |
2 |
|||
4000.0 |
A |
0 |
0 |
0 |
1 |
2 |
3 |
2.50 |
2.72 |
B |
0 |
0 |
0 |
1 |
1 |
1 |
|||
Positive control (EMS) 300.0 |
A |
34 |
36 |
39 |
40 |
41 |
56 |
198.62 |
231.59 |
B |
71 |
77 |
77 |
77 |
80 |
87 |
|||
# concentrations related to the aqueous test substance a) Number of colonies 7 days after seeding about 300 .000 cells/flask into selection medium b) Correction applies to the absolute cloning efficiency at the end of the expression period |
Table 4: Experiment 2: Mutant Frequency (with metabolic activation)
Conc. [µg/mL] |
Culture |
No. of colonies a) |
Mutant frequency (per 10E6 cells) |
||||||
Not corrected |
Corrected b) |
||||||||
Vehicle control (Ham’s F12) |
A |
0 |
0 |
0 |
2 |
3 |
4 |
3.61 |
4.11 |
B |
0 |
0 |
0 |
1 |
1 |
2 |
|||
250.0# |
A |
0 |
1 |
1 |
1 |
2 |
2 |
5.28 |
5.16 |
B |
0 |
1 |
2 |
2 |
3 |
4 |
|||
500.0 |
A |
0 |
0 |
0 |
0 |
0 |
0 |
0.56 |
0.49 |
B |
0 |
0 |
0 |
0 |
1 |
1 |
|||
1000.0 |
A |
0 |
0 |
0 |
0 |
0 |
1 |
4.73 |
5.82 |
B |
1 |
2 |
3 |
3 |
3 |
4 |
|||
2000.0 |
A |
0 |
0 |
0 |
0 |
1 |
1 |
4.17 |
4.63 |
B |
1 |
1 |
2 |
2 |
3 |
4 |
|||
3000.0 |
A |
1 |
1 |
2 |
2 |
3 |
4 |
4.72 |
5.22 |
B |
0 |
0 |
0 |
1 |
1 |
2 |
|||
4000.0 |
A |
0 |
0 |
0 |
0 |
0 |
0 |
1.11 |
1.20 |
B |
0 |
0 |
1 |
1 |
1 |
1 |
|||
Positive control (EMS) 300.0 |
A |
35 |
40 |
42 |
43 |
47 |
47 |
120.84 |
128.78 |
B |
25 |
26 |
29 |
30 |
33 |
38 |
|||
# concentrations related to the aqueous test substance a) Number of colonies 7 days after seeding about 300 .000 cells/flask into selection medium b) Correction applies to the absolute cloning efficiency at the end of the expression period |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Ames test
A bacterial reverse mutation test compliant to OECD 471 was conducted under GLP conditions. The test substance was tested for its mutagenic potential in the Ames and the Escherichia coli (E. coli) reverse mutation assay. Salmonella typhimurium strains TA 1535, TA 100, TA 1537 and TA 98 as well as E. coli strain WP2 uvr were tested in the concentration range (based on the aqueous test substance) of 100 - 7500 µg/plate. Standard plate tests and preincubation tests both with and without metabolic activation (S9 fraction of Aroclor 1254 induced male Sprague-Dawley rat liver) were performed. The test substance was completely soluble and no precipitation occurred. No bacteriotoxic effect was noted up to the highest concentration of 7500 µg/plate tested. An increase in the number of his+ or trp+ revertants was not observed both in the standard plate test and in the preincubation test either without S9 mix or after the addition of the metabolizing system. Thus, the test substance was not mutagenic in the Ames and Escherichia reverse mutation assay under the experimental conditions chosen (BASF SE, 1989).
HPRT test
The test substance was investigated for its ability to induce gene mutations at the hypoxanthine-guanine phosphoribosyl transferase (HPRT) locus in Chinese Hamster Ovary (CHO) cells in vitro according to OECD 476 under GLP conditions. Two independent experiments were carried out, both with and without metabolic activation (S9 fraction of Aroclor 1254 induced rat liver). According to an initial range-finding cytotoxicity test for the determination of the experimental doses, the test substance did not exhibit any pronounced toxicity up to the highest possible recommended concentration, i .e . 10 mM (based on the active ingredient). In experiment 1 concentrations in the range (based on the aqueous test substance) between 240.625 - 3850.0 µg/mL were tested, while in experiment 2 concentrations (based on the aqueous test substance) ranged between 250.0 - 4000 µg/mL.
After an attachment period of 20 - 24 hours, a treatment period of 4 hours both with and without metabolic activation and a selection period of about
1 week, the colonies of each test group were fixed with methanol, stained with Giemsa and counted. The negative controls (vehicle controls) gave mutant frequencies within the range expected for the CHO cell line. Both of the positive control chemicals, i.e. EMS and MCA, led to the expected increase in the frequencies of forward mutations.
The test substance did not cause an increase in the mutant frequencies either without S9 mix or after adding a metabolizing system in two experiments performed independently of each other. Thus, under the experimental conditions of this assay the test substance was not considered to be mutagenic under in vitro conditions in the HPRT locus assay using CHO cells (BASF SE, 1997).
Chromosome aberration test
The test substance was investigated for induction of structural and numerical chromosome aberrations in V79 cell line in vitro (lung fibroblasts of a Chinese hamster) according to OECD guideline 473 under GLP conditions. According to an initial range-finding cytotoxicity test for the determination of the highest experimental doses, the test substance did not exhibit any toxicity up to the highest recommended concentration, i .e . 10 mM (based on the active ingredient) . The following doses (based on the aqueous test substance) were evaluated in the 1st experiment: Without and with S9 mix ; 18 hours harvest time: 0, 962.5, 1925, 3850 µg/mL.
For confirmation of the findings of the 1st experiment the 2nd experiment was limited to the experiment without S9 mix only but selecting close doses: Without S-9 mix, 18 hours harvest time: 0; 1925, 2887.5, 3850 µg/mL.
In a 3rd experiment for further confirmation including a second harvest time, the following doses were analyzed:
- without and with S9 mix; 18 hours harvest time: 0, 1925, 2887.5, 3850 µg/mL
- without and with S9 mix; 28 hours harvest time: 0, 3850 µg/mL.
Chromosomes were prepared 18 hours (low, intermediate and top dose) and 28 hours (top dose only) after test substance treatment, which lasted for about 4 hours in the experiments with S9 mix or for about 18 hours without metabolic activation. Duplicate cultures were used for all experimental groups. About 2- 3 hours prior to harvesting the cells, colcemid was added to arrest cells in a metaphase like stage of mitosis (c-metaphases). After preparation of the chromosomes and staining with Giemsa, 100 metaphases of each culture in the case of the test substance and vehicle controls, or 50 cells of each culture in the case of the concurrent positive controls, were analyzed for chromosomal aberrations.
The negative controls gave frequencies of aberrations within the range expected for the V79 cell line. Both of the positive control chemicals, i .e . EMS and cyclophosphamide, led to the expected increase in the number of cells containing structural chromosomal aberrations. The test substance did not cause an increase in the number of structurally aberrant metaphases including/excluding gaps at both sampling times either without S9 mix or after adding a metabolizing system in two experiments performed independently of each other. No increase in the frequency of cells containing numerical aberrations was demonstrated either. Thus, under the experimental conditions of this study, the test substance was not chromosome-damaging (clastogenic) under in vitro conditions in V79 cells (BASF SE, 1997).
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation (EC) No 1272/2008. As a result, the substance is not considered to be classified for genetic toxicity under Regulation (EC) No 1272/2008, as amended for the tenth time in Regulation (EC) No 2017/776.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
